UroLift as a surrogate for fiducial markers in IGRT planning of prostate cancer in BPH patients

Pract Radiat Oncol. 2018 Jul-Aug;8(4):e231-e233. doi: 10.1016/j.prro.2017.11.014. Epub 2017 Dec 24.

¹ Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey; Department of Radiation Oncology, Robert Wood Johnson University Hospital, Hamilton, New Jersey. Electronic address: [email protected].
² Department of Radiation Oncology, Robert Wood Johnson University Hospital, Hamilton, New Jersey.
³ Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey; Department of Radiation Oncology, Robert Wood Johnson University Hospital, Hamilton, New Jersey.

No abstract available

Publication types